EQUIPALAZONE® 1G ORAL POWDER from £74.85

Presentation:

Oral powder. White/cream powder.

Uses:

For the treatment of musculoskeletal disorders in horses and ponies where the anti-inflammatory and analgesic properties of phenylbutazone can offer relief. Examples of conditions normally considered suitable for treatment with phenylbutazone include lameness associated with osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis, and in the reduction of post-surgical soft tissue reaction.

Dosage and administration:

For oral administration only. The dosage should be adjusted according to the individual animal’s response, but the following may be taken as a guide:

Horses: 450 kg (1000 lb) body weight: the contents of two sachets to be administered twice on day 1 of treatment (equivalent to 8.8 mg/kg/day) followed by the contents of one sachet twice daily for four days (4.4 mg/kg/day), then one sachet daily, or on alternate days, sufficient to keep the horse comfortable (2.2 mg/kg/day).

Ponies: 225 kg (500 lb) body weight, one sachet (4.4 mg/kg) on alternate days.

Discontinue treatment if no response is evident after four to five days treatment.

For ease of administration mix the powder with a small quantity of feed.

Horses: Not for use in horses intended for human consumption. Treated horses should never be slaughtered for human consumption. The horse must be declared as not intended for human consumption under national horse passport regulation.